These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38613220)

  • 21. Favourable clinical outcomes and low revision rate after M-ACI in adolescents with immature cartilage compared to adult controls: Results at 10 years.
    Weishorn J; Wiegand J; Koch KA; Trefzer R; Renkawitz T; Walker T; Bangert Y
    Knee Surg Sports Traumatol Arthrosc; 2024 Jul; ():. PubMed ID: 39010715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Third-Generation Autologous Chondrocyte Implantation at the Knee Joint Using the Igor Scaffold: A Case Series With 2-Year Follow-up.
    Zak L; Kleiner A; Albrecht C; Tichy B; Aldrian S
    Orthop J Sports Med; 2021 Jan; 9(1):2325967120969237. PubMed ID: 33553440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Costal Chondrocyte-Derived Pellet-Type Autologous Chondrocyte Implantation Versus Microfracture for the Treatment of Articular Cartilage Defects: A 5-Year Follow-up of a Prospective Randomized Trial.
    Yoon KH; Lee J; Park JY
    Am J Sports Med; 2024 Feb; 52(2):362-367. PubMed ID: 38230875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Injectable autologous chondrocyte implantation in acetabular cartilage defects: 2-year minimum clinical and MRI results.
    Krueger DR; Baur ADJ; Perka C; Schroeder JH
    Arch Orthop Trauma Surg; 2023 Feb; 143(2):739-747. PubMed ID: 34468836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Prospective, Randomized, Open-Label, Multicenter, Phase III Noninferiority Trial to Compare the Clinical Efficacy of Matrix-Associated Autologous Chondrocyte Implantation With Spheroid Technology Versus Arthroscopic Microfracture for Cartilage Defects of the Knee.
    Niemeyer P; Laute V; Zinser W; Becher C; Kolombe T; Fay J; Pietsch S; Kuźma T; Widuchowski W; Fickert S
    Orthop J Sports Med; 2019 Jul; 7(7):2325967119854442. PubMed ID: 31317047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcomes after first-generation autologous chondrocyte implantation for cartilage defects of the knee.
    Niemeyer P; Porichis S; Steinwachs M; Erggelet C; Kreuz PC; Schmal H; Uhl M; Ghanem N; Südkamp NP; Salzmann G
    Am J Sports Med; 2014 Jan; 42(1):150-7. PubMed ID: 24145948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of symptomatic cartilage defects of the knee: characterized chondrocyte implantation results in better clinical outcome at 36 months in a randomized trial compared to microfracture.
    Saris DB; Vanlauwe J; Victor J; Almqvist KF; Verdonk R; Bellemans J; Luyten FP;
    Am J Sports Med; 2009 Nov; 37 Suppl 1():10S-19S. PubMed ID: 19846694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reliability of the MOCART (Magnetic Resonance Observation of Cartilage Repair Tissue) 2.0 knee score for different cartilage repair techniques-a retrospective observational study.
    Schreiner MM; Raudner M; Röhrich S; Zalaudek M; Weber M; Kaiser G; Aldrian S; Chiari C; Windhager R; Trattnig S
    Eur Radiol; 2021 Aug; 31(8):5734-5745. PubMed ID: 33515088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term Assessment of Subchondral Bone Changes and Intralesional Bony Overgrowth After Third-Generation Autologous Chondrocyte Implantation: A Retrospective Study.
    Zak L; Kleiner A; Trattnig S; Albrecht C; Aldrian S
    Am J Sports Med; 2023 May; 51(6):1414-1421. PubMed ID: 37070725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix-induced autologous chondrocyte implantation (MACI) for chondral defects in the patellofemoral joint.
    Meyerkort D; Ebert JR; Ackland TR; Robertson WB; Fallon M; Zheng MH; Wood DJ
    Knee Surg Sports Traumatol Arthrosc; 2014 Oct; 22(10):2522-30. PubMed ID: 24817164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arthroscopic Matrix-Assisted Autologous Chondrocyte Transplantation Versus Microfracture: A 6-Year Follow-up of a Prospective Randomized Trial.
    Ibarra C; Villalobos E; Madrazo-Ibarra A; Velasquillo C; Martinez-Lopez V; Izaguirre A; Olivos-Meza A; Cortes-Gonzalez S; Perez-Jimenez FJ; Vargas-Ramirez A; Franco-Sanchez G; Ibarra-Ibarra LG; Sierra-Suarez L; Almazan A; Ortega-Sanchez C; Trueba C; Martin FB; Arredondo-Valdes R; Chavez-Arias D
    Am J Sports Med; 2021 Jul; 49(8):2165-2176. PubMed ID: 34048286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Costal Chondrocyte-Derived Pellet-Type Autologous Chondrocyte Implantation versus Microfracture for Repair of Articular Cartilage Defects: A Prospective Randomized Trial.
    Yoon KH; Yoo JD; Choi CH; Lee J; Lee JY; Kim SG; Park JY
    Cartilage; 2021 Dec; 13(1_suppl):1092S-1104S. PubMed ID: 32476445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective Long-term Follow-up of Autologous Chondrocyte Implantation With Periosteum Versus Matrix-Associated Autologous Chondrocyte Implantation: A Randomized Clinical Trial.
    Barié A; Kruck P; Sorbi R; Rehnitz C; Oberle D; Walker T; Zeifang F; Moradi B
    Am J Sports Med; 2020 Jul; 48(9):2230-2241. PubMed ID: 32667270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved outcomes with combined autologous chondrocyte implantation and patellofemoral osteotomy versus isolated autologous chondrocyte implantation.
    Trinh TQ; Harris JD; Siston RA; Flanigan DC
    Arthroscopy; 2013 Mar; 29(3):566-74. PubMed ID: 23312875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microfracture Versus Autologous Chondrocyte Implantation for Articular Cartilage Lesions in the Knee: A Systematic Review of 5-Year Outcomes.
    Kraeutler MJ; Belk JW; Purcell JM; McCarty EC
    Am J Sports Med; 2018 Mar; 46(4):995-999. PubMed ID: 28423287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acellular Matrix-Induced Chondrogenesis Technique Improves the Results of Chondral Lesions Associated With Femoroacetabular Impingement.
    De Lucas Villarrubia JC; Méndez Alonso MÁ; Sanz Pérez MI; Trell Lesmes F; Panadero Tapia A
    Arthroscopy; 2022 Apr; 38(4):1166-1178. PubMed ID: 34437943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 10-Year Prospective Clinical and Radiological Evaluation After Matrix-Induced Autologous Chondrocyte Implantation and Comparison of Tibiofemoral and Patellofemoral Graft Outcomes.
    Ebert JR; Zheng M; Fallon M; Wood DJ; Janes GC
    Am J Sports Med; 2024 Mar; 52(4):977-986. PubMed ID: 38384192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time to Achieving Clinically Significant Outcomes After Meniscal Allograft Transplantation.
    Huddleston HP; Polce EM; Gilat R; Mehta N; Alzein M; Dandu N; Parvaresh KC; Cole BJ; Yanke AB
    Cartilage; 2022; 13(3):19476035221102568. PubMed ID: 35864782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterized chondrocyte implantation in the patellofemoral joint: an up to 4-year follow-up of a prospective cohort of 38 patients.
    Vanlauwe JJ; Claes T; Van Assche D; Bellemans J; Luyten FP
    Am J Sports Med; 2012 Aug; 40(8):1799-807. PubMed ID: 22785604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining the minimal clinically important difference for IKDC and KOOS scores for patients undergoing tibial tubercle osteotomy for patellofemoral pain or instability.
    Retzky JS; Shah AK; Neijna AG; Rizy ME; Gomoll AH; Strickland SM
    J Exp Orthop; 2024 Jul; 11(3):e12115. PubMed ID: 39076849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.